Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders
References (110)
- et al.
Benzoquinolizine derivatives: A new class of monoamine decreasing drugs with psychotropic action
Int Rev Neurobiol
(1962) - et al.
Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles
Biochem Pharmacol
(1989) - et al.
Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine
JBiol Chem
(1996) - et al.
Synaptic vesicular monoamine transporter expression: Distribution and pharmacologic profile
Brain Res Mol Brain Res
(1994) - et al.
A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea
Lancet
(1974) - et al.
Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease
Neuropharmacology
(1988) - et al.
Metabolic studies of tetrabenazine, a psychotropic drug in animals and man
Biochem Pharmacol
(1966) - et al.
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine
Life Sci
(1983) - et al.
Neurotransmitter depleter tetrabenazine; potential candidate for schizophrenia treatment?
Schizophr Res
(2007) - et al.
Pelvic dyskinesia with an outstanding response to tetrabenazine
Prog Neuropsychopharmacol Biol Psychiatry
(2009)
Letter: Tetrabenazine in chorea
Lancet
(1974)
Tetrabenazine (Xenazine) for Huntington's chorea
Med Lett Drugs Ther
(2009)
Tetrabenazine (Nitoman) in the treatment of psychoses. With a discussion on the central mode of action of tetrabenazine and reserpine
Acta Psychiatr Scand
(1963)
Tetrabenazine (Xenazine tablets) [package insert]
(May 2008)
Experimentelle Untersuchungen zur Pharmakologie des mit 3H-markierten tetra-benazines
Arzneim Forsch
(1961)
In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography
J Neurochem
(1993)
Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies
Drug Metab Dispos
(1987)
The pharmacokinetics of tetrabenazine and its hydroxyl metabolite in patients treated for involuntary movement disorders
Eur J Clin Pharmacol
(1986)
Absolute configuration of (+)-alpha-dihydrotetrabenazine, an active metabolite of tetrabenazine
Chirality
(1997)
Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine
Psychopharmacologia
(1975)
Reversal of hemiballismus by tetrabenazine
JAMA
(1972)
Hemiballism in multiple sclerosis
Mov Disord
(1988)
Coprolalia associated with hemiballismus: Response to tetrabenazine
Clin Neuropharmacol
(1985)
Hemiballismus
Ir Med J
(2002)
Hemiballism-hemichorea Clinical and pharmacologic findings in 21 patients
Arch Neurol
(1989)
Acute bilateral ballism in a patient with intravascular dissemination of gastric carcinoma
Neuropathol Appl Neurobiol
(1992)
Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus
Mov Disord
(2006)
Hemichorea, moya-moya, and ulcerative colitis
Mov Disord
(2001)
Tetrabenacine treatment in persisting dyskinesia caused by psychopharmaca
Am J Psychiatry
(1961)
Tetrabenazine for extra-pyramidal movement disorders
Br Med J
(1970)
Metoclopramide induced tardive dyskinesia
J Indian Med Assoc
(1991)
Laryngeal tardive dyskinesia
J Neurol
(1995)
Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride
Int J Clin Pract
(2003)
Tardive tremor
Mov Disord
(1992)
Tardive tremor
Mov Disord
(1997)
Tardive dystonia in patients with Tourette's syndrome
Mov Disord
(1988)
Olanzapine-induced tardive dystonia successfully treated by tetrabenazine
J Neuropsychiatry Clin Neurosci
(2007)
Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine
J Nerv Ment Dis
(1993)
Tardive oculogyric crises
Neurology
(1989)
Tetrabenazine for Huntington's chorea
Br Med J
(1970)
Spinal myoclonus
Neurology
(1977)
Segmental myoclonus. Clinical and pharmacologic study
Arch Neurol
(1986)
Tetrabenazine in Sydenham's chorea
Br Med J
(1977)
What is it? Case 2, 1991: Unusual tremor, myoclonus, and a limping gait
Mov Disord
(1991)
Generalized chorea induced by nonketotic hyperglycemia
Mov Disord
(1993)
Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)
Mov Disord
(2005)
Involvement of respiratory muscles in adult-onset dystonia: A clinical and electrophysiological study
Mov Disord
(1995)
Tetrabenazine in the treatment of senile vocal tics
J Neurol
(1987)
Eating dysfunction associated with oromandibular dystonia: Clinical characteristics and treatment considerations
Head Face Med
(2006)
Cited by (117)
Synthesis of Pyrido-[2,1-a]isoquinoline Derivatives via Gold(I)-Catalyzed Intramolecular Cascade Reaction of Enamides
2024, Advanced Synthesis and CatalysisComplexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia
2022, Brain Research BulletinCitation Excerpt :Additional animal models have studied the effects of peripheral or intra-accumbens injections of the VMAT-2 inhibitor tetrabenazine (TBZ; Nunes et al., 2013; Randall et al., 2014; Yohn et al., 2015a,b, 2016a,b,c; Pardo et al., 2015). TBZ is used in animal models because this drug produces depressive symptoms, including fatigue and apathy, in people (Frank, 2009, 2010; Guay, 2010; Chen et al., 2012). TBZ produces a low-effort bias in rats responding on the FR5/chow feeding choice procedure, decreasing lever pressing but increasing chow intake (Nunes et al., 2013; Yohn et al., 2016a).
Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders
2020, Parkinsonism and Related DisordersSynthesis of Benzo[a]quinolizidines via an Aza-Michael/Oxidative Mannich Process
2019, Asian Journal of Organic Chemistry
Copyright © 2010 Excerpta Medica Inc. All rights reserved.